Increased urinary albumin excretion in uncomplicated hypertension has been associated recently with impaired vascular reactivity (nitric oxide (NO)-dependent and -independent vasodilation) 1 and increased levels of adhesion molecules, 2 thereby suggesting that endothelial dysfunction is responsible for the increased cardiovascular (CV) risk associated with albuminuria. 1, 2 In light of these reports, we have used our human model of vascular tone control, Bartter's/Gitelman's syndromes (BS/ GS) patients who have biochemical and hormonal characteristics typical of hypertension, yet normotension/hypotension, hyporesponsiveness to pressors and have reduced vascular resistance, [3] [4] [5] to assess the urinary albumin/creatinine ratio (UACR) as a potential marker of endothelial dysfunction. We found that UACR in BS/GS did not differ from healthy subjects, contrary to that found in hypertensive patients, thereby indirectly providing further support for the fact that increased UACR reflects endothelial dysfunction and its associated increased CV risk.
Microalbuminuria (urinary albumin excretion of 30-300 mg/24 h or 20-200 mg/min) in patients with essential hypertension predicts the decline of renal function and is associated with target organ damage and increased risk of adverse CV events, [6] [7] while the reduction of microalbuminuria with antihypertensive treatment is accompanied by a decrease in CV risk. The recent association found in hypertensive subjects between increased urinary albumin excretion and impaired vascular reactivity (NO-dependent and -independent vasodilation) 1 and greater levels of adhesion molecules 2 points toward a potential mechanism linking the increased albuminuria with CV risk via the early induction of endothelial dysfunction. 1, 2 The possibility of confirming this mechanism could come from the study of a human model for vascular tone and structure regulation, which has biochemical and hormonal characteristics typical of hypertension, yet hyporesponsive to pressors and has reduced vascular resistance and normotension/hypotension, such as BS/GS. [3] [4] [5] Angiotensin II has been shown to play a major role in the pathogenesis of CV and renal diseases through the demonstration that Ang II itself is a powerful proinflammatory cytokine and growth factor. 8 Given the emergence of Ang II as a common pathway in cardiovascular diseases, atherosclerosis and inflammation, 8, 9 we have used BS/GS as a model for the study of Ang II biology. [3] [4] [5] Our extensive series of studies have sought to provide mechanistic explanations for the vascular hyporeactivity typical of these patients and has led us to propose that BS/GS is a good human model to explore the mechanisms responsible for maintenance/controlling vascular tone and vascular remodelling. [3] [4] [5] In BS/GS we have demonstrated that the short-term Ang II signalling pathway is blunted as documented by the increased RGS-2 gene and protein expression, reduced gene and protein expression of the a subunit of the Gq binding protein, which transduces Ang II signal, reduced related downstream cellular events such as intracellular Ca 2 þ and IP 3 release, and PKC activity. [3] [4] [5] This abnormal G protein-mediated signaling of Ang II shown in BS/GS patients, combined with downregulation of RhoA/Rho-kinase pathway, 5 upregulation of NO system, 10 reduced peripheral resistance, vascular hyporeactivity, normotension/ hypotension typical of these patients and their collection of biochemical characteristics, presents a mirror image of that found in hypertension. [3] [4] [5] Therefore, understanding why BS/GS patients do not develop hypertension and activation of biochemical and molecular pathways that link hypertension, inflammation and remodeling despite increased level of Ang II and activation of the reninangiotensin-aldosterone system (RAAS) may shed considerable light on the cellular basis of these relationships in hypertensive patients.
Increased urinary albumin excretion in hypertensive patients has been recently associated with impaired NO-dependent and -independent vascular reactivity 1 and greater levels of adhesion molecules, 2 which points towards endothelial dysfunction as a potential mechanism for the increased CV risk associated with albuminuria.
1,2 To increase our understanding of the association of endothelial dysfunction and albuminuria with increased CV risk, we have measured UACR in our cohort of extensively characterized 12 BS/GS patients, 2 BS and 10 GS. [3] [4] [5] Twelve sex-and age-matched normotensive healthy subjects from the staff of the Department of Clinical and Experimental Medicine at the University of Padova were used as controls. None of the patients or controls took drugs for at least 2 weeks before the study and all abstained from food, alcohol and caffeine-containing drinks for at least 12 h before sample collection. The first voided urine was collected on the morning of the study and stored at À201C until analysed. Urinary albumin was evaluated by a nephelometric assay using a nephelometer (BN II Dade Behring, Milan, Italy), and creatinine was measured by Jaffè colorimetric method using a Modular P Analyzer (Roche Diagnostics, Milan, Italy), and urinary albumin excretion was expressed as urinary albumin/creatinine ratio (UACR, mg/g), which is commonly used in large epidemiological studies. Clinical and laboratory characteristics of patients and controls are shown in Table 1 .
Urinary albumin excretion was in the normal range (0-30 mg/g Cr) in BS/GS patients and similar to that found in healthy controls (12.0778.3 mg/g Cr vs 11.579.2, P ¼ ns).
We have provided evidence that in BS/GS, certain Ang II signaling pathways are altered and that these alterations provide an explanation for the fact that BS/GS do not develop hypertension and related diseases such as atherosclerosis and cardiovascular remodeling, in spite of their high Ang II level and activation of the RAAS. [3] [4] [5] In addition, we have recently determined the level of C-reactive protein (CRP), the best known and the most commonly used indicator of inflammation as well as that of acute-phase reactants such as serum amyloid A (SAA), soluble vascular cell adhesion molecule and intercellular adhesion molecule, and inflammatory processes-related cytokines such as interleukin-6 (IL-6) and TNF-a. 11 Our results have demonstrated that BS/GS patients had unchanged levels of all these inflammatory markers compared with healthy subjects. 11 The current findings lend further confirmation, as in BS/GS UACR did not differ from healthy subjects and are perfectly in keeping with the evidence of a markedly higher insulin sensitivity compared with healthy normotensive subjects in these patients, 12 and an Ang II signaling/insulin-glucose metabolism relationships, which point toward reduced insulin resistance that are opposite of those typical of diabetes and hypertension, 5, 12 including the absence of microalbuminuria and endothelial dysfunction. This evidence in BS/GS is sustained by reduced oxidative stress 5 and inflammatory status, 11 upregulation of NO system, 4,5,10 downregulation of RhoA-Rho kinase pathway, 5 activation of Akt pathway 5 and blunted Ang II signaling, 4, 5 which, combined with the absence of albuminuria, depict a biochemical and molecular picture of reduced CV risk and therefore indirectly support the association of endothelial dysfunction and albuminuria with increased CV risk. 
